Pharmaceutical preparations and substances for the treatment of osteoporosis; pharmaceutical preparations and substances for the alleviation of osteoporosis-related symptoms; pharmaceutical preparations and substances for the treatment of cartilage disorders; pharmaceutical preparations and substances for the treatment of bone disorders; pharmaceutical preparations and substances for the treatment of bone loss; pharmaceutical preparations and substances for the alleviation of bone-loss related symptoms; pharmaceutical preparations and substances for use in endocrinology; pharmaceutical preparations and substances for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures; pharmaceutical preparations and substances for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures; pharmaceutical preparations and substances for the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture; pharmaceutical preparations for the treatment of menopause; pharmaceutical preparations and substances for the alleviation of menopause-related symptoms; pharmaceutical preparations and substances for use in relation to women’s health; pharmaceutical preparations and substances for use in rheumatology; pharmaceutical preparations and substances for the treatment of arthritis; pharmaceutical preparations and substances for the treatment of rheumatoid arthritis; pharmaceutical preparations and substances for the treatment of juvenile idiopathic polyarthritis; pharmaceutical preparations and substances for the treatment of active systemic juvenile idiopathic arthritis; pharmaceutical preparations and substances for use in endocrinology; pharmaceutical preparations and substances for use in the treatment of respiratory conditions; pharmaceutical preparations and substances for use in the treatment of coronavirus disease;; pharmaceutical preparations and substances for use in the treatment of cytokine release syndrome; all the above being for human use.

Commercial and industrial electric luminaires for outdoor use using light-emitting diodes as their light source, and commercial and industrial electric luminaires using light-emitting diodes as their light source for indoor factory, warehouse and loading-dock area illumination and for indirect lighting for commercial office spaces.

Skincare cosmetics; Skincare preparations (cosmetic); Beauty care products; Beauty care preparations; Beauty creams (non-medicated); Beauty face packs; Beauty gels

Advisory services relating to beauty treatment; Beauty care services; Beauty consultancy; Beauty consultation; Beauty counselling; Beauty salon services; Beauty salons; Beauty treatment services; Consultancy relating to beauty; Consultancy relating to beauty care; Consultancy services relating to personal appearance (hair, beauty, cosmetics); Health spas (health, hygiene and beauty care services); Hygienic and beauty care for animals; Hygienic and beauty care for human beings; Personal care services (medical nursing, health, hygiene and beauty care); Providing information, including online, about hygienic and beauty care for human beings or animals

Software development, programming and implementation; it consultancy, advisory and information services; design and development of data processing systems; creation of computing platforms for third parties; development of computer systems; outsource service providers in the field of information technology; engineering services relating to computers.

testing of computer programs; computer software development; testing of computers; software engineering; testing of computer installations; development of computer software application solutions; computer software engineering; development of computer software; maintenance of computer software; computer software consultancy; installation of computer software; technical diagnostic testing services; computer software design; technical testing services; testing of computing equipment; development of software; updating of computer software; installation of middleware (software); design of computer software; computer software advisory services; computer security services (testing and risk assessment of computer networks); installation and maintenance of computer software; information technology (it) services (computer hardware, software and peripherals design and technical consultancy); software development in the framework of software publishing; repair of computer software; scientific testing services; development of testing methods; software creation

Crowdfunding services, namely the issuance of bonds to secure mortgage deposits from investors and acquirers; Crowd funding services, namely the settlement of bonds upon maturity by issuers

Pharmaceutical preparations and substances for the treatment of osteoporosis; pharmaceutical preparations and substances for the alleviation of osteoporosis-related symptoms; pharmaceutical preparations and substances for the treatment of cartilage disorders; pharmaceutical preparations and substances for the treatment of bone disorders; pharmaceutical preparations and substances for the treatment of bone loss; pharmaceutical preparations and substances for the alleviation of bone-loss related symptoms; pharmaceutical preparations and substances for use in endocrinology; pharmaceutical preparations and substances for the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures; pharmaceutical preparations and substances for the treatment of bone loss associated with hormone ablation in men with prostate cancer at increased risk of fractures; pharmaceutical preparations and substances for the treatment of bone loss associated with long-term systemic glucocorticoid therapy in adult patients at increased risk of fracture; pharmaceutical preparations for the treatment of menopause; pharmaceutical preparations and substances for the alleviation of menopause-related symptoms; pharmaceutical preparations and substances for use in relation to women’s health; pharmaceutical preparations and substances for use in rheumatology; pharmaceutical preparations and substances for the treatment of arthritis; pharmaceutical preparations and substances for the treatment of rheumatoid arthritis; pharmaceutical preparations and substances for the treatment of juvenile idiopathic polyarthritis; pharmaceutical preparations and substances for the treatment of active systemic juvenile idiopathic arthritis; pharmaceutical preparations and substances for use in endocrinology; pharmaceutical preparations and substances for use in the treatment of respiratory conditions; pharmaceutical preparations and substances for use in the treatment of coronavirus disease;; pharmaceutical preparations and substances for use in the treatment of cytokine release syndrome; all the above being for human use.

Financial services; mortgage services, including finance, advisory, brokerage,, investment, insurance, lending, investment management, and savings services; crowdfunding services, namely the issuance of bonds to secure mortgage deposits from investors and acquirers; crowd funding services, namely the settlement of bonds upon maturity by issuers; real estate affairs, including advisory services relating to real estate ownership and real estate valuations; insurance services relating to real estate